CDK4 and breast cancer: In cluster 2, which is enriched for ER+ and/or HER2+ breast cancer and Ewing sarcoma, many cell lines that were sensitive to CDK4 loss were less affected by CDK2 depletion, suggesting a reciprocal relationship in the requirements of these kinases (Fig. 1B, C and Supp Fig. S1A).